» Articles » PMID: 20809066

Brain Iron Metabolism and Its Perturbation in Neurological Diseases

Overview
Specialties Neurology
Physiology
Date 2010 Sep 3
PMID 20809066
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Metal ions are of particular importance in brain function, notably iron. A broad overview of iron metabolism and its homeostasis both at the cellular level (involving regulation at the level of mRNA translation) and the systemic level (involving the peptide 'hormone' hepcidin) is presented. The mechanisms of iron transport both across the blood-brain barrier and within the brain are then examined. The importance of iron in the developing foetus and in early life is underlined. We then review the growing corpus of evidence that many neurodegenerative diseases (NDs) are the consequence of dysregulation of brain iron homeostasis. This results in the production of reactive oxygen species, generating reactive aldehydes, which, together with further oxidative insults, causes oxidative modification of proteins, manifested by carbonyl formation. These misfolded and damaged proteins overwhelm the ubiquitin/proteasome system, accumulating the characteristic inclusion bodies found in many NDs. The involvement of iron in Alzheimer's disease and Parkinson's disease is then examined, with emphasis on recent data linking in particular interactions between iron homeostasis and key disease proteins. We conclude that there is overwhelming evidence for a direct involvement of iron in NDs.

Citing Articles

Selenoproteins: Zoom-In to Their Metal-Binding Properties in Neurodegenerative Diseases.

Duta C, Muscurel C, Dogaru C, Stoian I Int J Mol Sci. 2025; 26(3).

PMID: 39941073 PMC: 11818150. DOI: 10.3390/ijms26031305.


The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Sub-Chronic 30 mg/kg Iron Treatment Induces Spatial Cognition Impairment and Brain Oxidative Stress in Wistar Rats.

Maaroufi K, Khadhraoui Y, Moulahi A, Ouarghi A, Poirot K, Save E Biol Trace Elem Res. 2025; .

PMID: 39810017 DOI: 10.1007/s12011-024-04511-y.


Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.

Sharma R, Yadav J, Bhat S, Musayev A, Myrzagulova S, Sharma D Mol Neurobiol. 2025; .

PMID: 39804528 DOI: 10.1007/s12035-024-04680-w.


Evaluating iron deposition in gray matter nuclei of patients with acute ischemic stroke using quantitative susceptibility mapping.

Zhou L, Yang J, Zhang W, Han L, Zhou S, Zheng C Front Neurol. 2025; 15:1518911.

PMID: 39744117 PMC: 11688647. DOI: 10.3389/fneur.2024.1518911.


References
1.
Zhang W, Liu J, Xu G, Yuan Q, Sayre L . Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem Res Toxicol. 2003; 16(4):512-23. DOI: 10.1021/tx020105a. View

2.
Burhans M, Dailey C, Beard Z, Wiesinger J, Murray-Kolb L, Jones B . Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci. 2005; 8(1):31-8. DOI: 10.1080/10284150500047070. View

3.
Fisher J, Devraj K, Ingram J, Slagle-Webb B, Madhankumar A, Liu X . Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol Cell Physiol. 2007; 293(2):C641-9. DOI: 10.1152/ajpcell.00599.2006. View

4.
Rao R, Tkac I, Townsend E, Gruetter R, Georgieff M . Perinatal iron deficiency alters the neurochemical profile of the developing rat hippocampus. J Nutr. 2003; 133(10):3215-21. DOI: 10.1093/jn/133.10.3215. View

5.
Zecca L, Youdim M, Riederer P, Connor J, Crichton R . Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004; 5(11):863-73. DOI: 10.1038/nrn1537. View